nodgoРоссийский журнал детской гематологии и онкологии (РЖДГиО)Russian Journal of Pediatric Hematology and Oncology2311-12672413-5496LTD “Graphica”10.21682/2311-1267-2019-6-4-69-75nodgo-556Research ArticleОБЗОРЫ ЛИТЕРАТУРЫLITERATURE REVIEWSВенозные тромбозы в детской онкологии (обзор литературы)Venous thrombosis in pediatric cancer (literature review)https://orcid.org/0000-0002-8279-1832УзуеваС. Ш.UzuevaS. Sh.

Селима Шамильевна Узуева - врач-гематолог консультативного отделения НМИЦ ДГОИ им. Дмитрия Рогачева.

117997, Москва, ул. Саморы Машела, 1

Hematologist Advisory Unit.

1 Samory Mashela St., Moscow, 117997

selimauzueva@gmail.comЖарковП. А.ZharkovP. A.

Доктор медицинских наук, врач-гематолог консультативного отделения, врач-педиатр стационара кратковременного лечения НМИЦ ДГОИ им. Дмитрия Рогачева.

117997, Москва, ул. Саморы Машела, 1

Dr. of Sci. (Med.), Hematologist Advisory Unit, Short-Term Hospital Pediatrician.

1 Samory Mashela St., Moscow, 117997

pzharkoff@gmail.comФГБУ «НМИЦДГОИ им. Дмитрия Рогачева» Минздрава РоссииРоссияDmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Ministry of Health of RussiaRussian Federation201922012020646975Copyright © Узуева С.Ш., Жарков П.А., 20202020Узуева С.Ш., Жарков П.А.Uzueva S.S., Zharkov P.A.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://journal.nodgo.org/jour/article/view/556

Развитие венозных тромбозов (ВТ) является частым осложнением в терапии детей со злокачественными новообразованиями (ЗНО). Патогенез ВТ у детей со ЗНО является мультифакторным, включающим изменения в системе гемостаза, вызываемые как самим первичным заболеванием, так и методами лечения.

Venous thromboembolism (VTE) is a frequent complication in children being treated for cancer. Pathogenesis of VTE in children with cancer is multifactorial, including changes in the hemostatic system caused by the primary disease itself as well as methods of treatment.

тромбоэмболиявенозный тромбозраксолидные опухолидетиthromboembolismvenous thrombosiscancersolid tumorschildrenReferencesAthale U., Siciliano S., Thabane L., Pai N., Cox S., Lathia A., Khan A., Armstrong A., Chan A.K. Epidemiology and clinical risk factors predisposing to thromboembolism in children with cancer. Pediatr Blood Cancer 2008;51(6):792-7. doi: 10.1002/pbc.21734.Athale U., Siciliano S., Thabane L., Pai N., Cox S., Lathia A., Khan A., Armstrong A., Chan A.K. Epidemiology and clinical risk factors predisposing to thromboembolism in children with cancer. Pediatr Blood Cancer 2008;51(6):792-7. doi: 10.1002/pbc.21734.Piovesan D., Attard C., Monagle P., Ignjatovic V. Epidemiology of venous thrombosis in children with cancer. Thromb Haemost 2014;111(06):1015–21. doi: 10.1160/TH13-10-0827.Piovesan D., Attard C., Monagle P., Ignjatovic V. Epidemiology of venous thrombosis in children with cancer. Thromb Haemost 2014;111(06): 1015—21. doi: Ш.Ш0/ТШ3-Ш-0827Tuckuviene R., Christensen A.L., Helgestad J., Johnsen S.P., Kristensen S.R. Pediatric venous and arterial noncerebral thromboembolism in Denmark: a nationwide population-based study. J Pediatr 2011;159(4):663-9. doi: m.m16/j.jpeds.20n.03.052.Tuckuviene R., Christensen A.L., Helgestad J., Johnsen S.P., Kristensen S.R. Pediatric venous and arterial noncerebral thromboembolism in Denmark: a nationwide population-based study. J Pediatr 2011;159(4):663-9. doi: m.m16/j.jpeds.20n.03.052.Spencer F., Emery C., Lessard D., Anderson F., Emani S., Aragam J., Becker R.C., Goldberg R.J. The Worcester Venous Thromboembolism study: a population-based study of the clinical epidemiology of venous thromboembolism. J Gen Intern Med 2006;21(7):722-7. doi: 10.1111/j.1525-1497.2006.00458.x.Spencer F., Emery C., Lessard D., Anderson F., Emani S., Aragam J., Becker R.C., Goldberg R.J. The Worcester Venous Thromboembolism study: a population-based study of the clinical epidemiology of venous thromboembolism. J Gen Intern Med 2006;21(7):722-7. doi: 10.1111/j.1525-1497.2006.00458.x.Жарков П.А., Румянцев А.Г, Новичкова ГА. Венозные тромбозы у детей со злокачественными новообразованиями (обзор литературы). Российский журнал детской гематологии и онкологии 2015;2(1):66-74. doi: 10.17650/2311-1267-2015-1-66-74.Zharkov P.A., Rumyantsev A.G., Novichkova G.A. Venous thromboembolism in children with cancer. Rossiyskiy zhurnal detskoy gematologii i onkologii = Russian Journal of Pediatric Hematology and Oncology 2015;2(1):66-74. (In Russ.).Raffini L., Huang Y.S., Witmer C., Feudtner C. Dramatic increase in venous thromboembolism in children’s hospitals in the United States from 2001 to 2007. Pediatrics 2009;124(4):1001-8. doi: 10.1542/peds.2009-0768.Raffini L., Huang Y.S., Witmer C., Feudtner C. Dramatic increase in venous thromboembolism in children’s hospitals in the United States from 2001 to 2007. Pediatrics 2009;124(4):1001-8. doi: 10.1542/peds.2009-0768.Walker A.J., Grainge M.J., Card T.R., West J., Ranta S., Ludvigsson J.F. Venous thromboembolism in children with cancer -a population-based cohort study. Thromb Res 2014;133(3):340-4. doi: 10.1016/j.thromres.2013.12.021.Walker A.J., Grainge M.J., Card T.R., West J., Ranta S., Ludvigsson J.F. Venous thromboembolism in children with cancer -a population-based cohort study. Thromb Res 2014;133(3):340-4. doi: 10.1016/j.thromres.2013.12.021.Radulescu V., D’Orazio J. Venous Thromboembolic Disease in Children and Adolescents. Adv Exp Med Biol 2017;906:149-65. doi: 10.1007/5584_2016_113.Radulescu V., D’Orazio J. Venous Thromboembolic Disease in Children and Adolescents. Adv Exp Med Biol 2017;906:149-65. doi: 10.1007/5584_2016_113.Esmon C. Basic mechanisms and pathogenesis of venous thrombosis. Blood Rev 2009;23(5):225-9. doi: 10.1016/j.blre.2009.07.002.Esmon C. Basic mechanisms and pathogenesis of venous thrombosis. Blood Rev 2009;23(5):225-9. doi: 10.1016/j.blre.2009.07.002.Varki A. Trousseau’s syndrome: multiple definitions and multiple mechanisms. Blood 2007;110:1723-9. doi: 10.1182/blood-2006-10-053736.Varki A. Trousseau’s syndrome: multiple definitions and multiple mechanisms. Blood 2007;110:1723-9. doi: 10.1182/blood-2006-10-053736.Carrier M., Le Gal G., Wells P.S., Fergusson D., Ramsay T., Rodger M.A. Systematic review: the Trousseau syndrome revisited: should we screen extensively for cancer in patients with venous thromboembolism? Ann Intern Med 2008;149(5):323-33. doi: 10.7326/0003-4819-149-5-200809020-00007.Carrier M., Le Gal G., Wells P.S., Fergusson D., Ramsay T., Rodger M.A. Systematic review: the Trousseau syndrome revisited: should we screen extensively for cancer in patients with venous thromboembolism? Ann Intern Med 2008;149(5):323-33. doi: 10.7326/0003-4819-149-5-200809020-00007.Skinner R., Koller K., McIntosh N., McCarthy A., Pizer B.; United Kingdom Children’s Cancer Study Group (UKCCSG); Paediatric Oncology Nursing Forum (PONF) Supportive Care Group. Prevention and management of central venous catheter occlusion and thrombosis in children with cancer. Pediatr Blood Cancer 2008;50(4):826-30. doi: 10.1002/pbc.21332.Skinner R., Koller K., McIntosh N., McCarthy A., Pizer B.; United Kingdom Children’s Cancer Study Group (UKCCSG); Paediatric Oncology Nursing Forum (PONF) Supportive Care Group. Prevention and management of central venous catheter occlusion and thrombosis in children with cancer. Pediatr Blood Cancer 2008;50(4):826-30. doi: 10.1002/pbc.21332.Bajzar L., Chan A., Massicotte M., Mitchell L. Thrombosis in children with malignancy. Curr Opin Pediatr 2006;18(1):1-9. doi: 10.1097/01.mop.0000193270.09001.ea.Bajzar L., Chan A., Massicotte M., Mitchell L. Thrombosis in children with malignancy. Curr Opin Pediatr 2006;18(1):1-9. doi: 10.1097/01.mop.0000193270.09001.ea.Petralia G., Lemoine N., Kakkar A. Mechanisms of disease: the impact of antithrombotic therapy in cancer patients. Nat Clin Pract Oncol 2005;2(7):356-63. doi: 10.1038/ncponc0225.Petralia G., Lemoine N., Kakkar A. Mechanisms of disease: the impact of antithrombotic therapy in cancer patients. Nat Clin Pract Oncol 2005;2(7):356-63. doi: 10.1038/ncponc0225.Olas B., Wachowicz B., Mielicki W. Cancer procoagulant and blood platelet activation. Cancer Lett 2001;169:165-71. doi: 10.1016/s0304-3835(01)00545-6.Olas B., Wachowicz B., Mielicki W. Cancer procoagulant and blood platelet activation. Cancer Lett 2001;169:165-71. doi: 10.1016/s0304-3835(01)00545-6.Stefansson S., McMahon G., Petitclerc E., Lawrence D. Plasminogen activator inhibitor-1 in tumor growth, angiogenesis and vascular remodeling. Curr Pharm Des 2003;9:1545-64. doi: 10.2174/1381612033454621.Stefansson S., McMahon G., Petitclerc E., Lawrence D. Plasminogen activator inhibitor-1 in tumor growth, angiogenesis and vascular remodeling. Curr Pharm Des 2003;9:1545-64. doi: 10.2174/1381612033454621.Deitcher S., Gajjar A., Kun L., Heideman R.L. Clinically evident venous thromboembolic events in children with brain tumors. J Pediatr 2004;145(6):848-50. doi: 10.1016/j.jpeds.2004.05.055.Deitcher S., Gajjar A., Kun L., Heideman R.L. Clinically evident venous thromboembolic events in children with brain tumors. J Pediatr 2004;145(6):848-50. doi: 10.1016/j.jpeds.2004.05.055.Athale U. Thrombosis in pediatric cancer: identifying the risk factors to improve care. Exp Rev Hematol 2013;6(5):599-609. doi: 10.1586/17474086.2013.842124.Athale U. Thrombosis in pediatric cancer: identifying the risk factors to improve care. Exp Rev Hematol 2013;6(5):599-609. doi: 10.1586/17474086.2013.842124.Athale U., Cox S., Siciliano S., Chan A.K. Thromboembolism in children with sarcoma. Pediatr Blood Cancer 2007;49(2):171-6. doi: 10.1016/j.thromres.2013.12.021.Athale U., Cox S., Siciliano S., Chan A.K. Thromboembolism in children with sarcoma. Pediatr Blood Cancer 2007;49(2):171-6. doi: 10.1016/j.thromres.2013.12.021.Deitcher S. Diagnosis, Treatment, and Prevention of Cancer-Related Venous Thrombosis. Abeloff’s Clinical Oncology (4th ed.), 2008. Part II (46). Pp. 693-711.Deitcher S. Diagnosis, Treatment, and Prevention of Cancer-Related Venous Thrombosis. Abeloff’s Clinical Oncology (4th ed.), 2008. Part II (46). Pp. 693-711.Journeycake J.M., Buchanan G.R. Catheter-related deep venous thrombosis and other catheter complications in children with cancer. J Clin Oncol 2006;24(28):4575-80. doi: 10.1200/JCO.2009.22.6126.Journeycake J.M., Buchanan G.R. Catheter-related deep venous thrombosis and other catheter complications in children with cancer. J Clin Oncol 2006;24(28):4575-80. doi: 10.1200/JCO.2009.22.6126.Kim S., Chung D. Pediatric solid malignancies: neuroblastoma and Wilms’ tumor. Surg Clin North Am 2006;86(2):469-87. doi: 10.1016/j.suc.2005.12.008.Kim S., Chung D. Pediatric solid malignancies: neuroblastoma and Wilms’ tumor. Surg Clin North Am 2006;86(2):469-87. doi: 10.1016/j.suc.2005.12.008.Wang J., Chen J.S., Chuang H.Y., Yang Y.J., Chang K.C., Wu J.M. Invasion of the cardiovascular system in childhood malignant hepatic tumors. J Pediatr Hematol Oncol 2002;24(6):436-9. doi: 10.1097/00043426-200208000-00006.Wang J., Chen J.S., Chuang H.Y., Yang Y.J., Chang K.C., Wu J.M. Invasion of the cardiovascular system in childhood malignant hepatic tumors. J Pediatr Hematol Oncol 2002;24(6):436-9. doi: 10.1097/00043426-200208000-00006.Paz-Priel I., Long L., Helman L.J., Mackall C.L., Wayne A.S. Thromboembolic events in children and young adults with pediatric sarcoma. J Clin Oncol 2007;25(12):1519-24. doi: 10.1200/JCO.2006.06.9930.Paz-Priel I., Long L., Helman L.J., Mackall C.L., Wayne A.S. Thromboembolic events in children and young adults with pediatric sarcoma. J Clin Oncol 2007;25(12):1519-24. doi: 10.1200/JCO.2006.06.9930.Agnelli G., Bolis G., Capussotti L., Scarpa R.M., Tonelli F., Bonizzoni E., Moia M., Parazzini F., Rossi R., Sonaglia F., Valarani B., Bianchini C., Gussoni G. A clinical outcome-based prospective study on venous thromboembolism after cancer surgery: the @RISTOS project. Ann Surg 2006;243(1):89-95. doi: 10.1097/01.sla.0000193959.44677.48.Agnelli G., Bolis G., Capussotti L., Scarpa R.M., Tonelli F., Bonizzoni E., Moia M., Parazzini F., Rossi R., Sonaglia F., Valarani B., Bianchini C., Gussoni G. A clinical outcome-based prospective study on venous thromboembolism after cancer surgery: the @RISTOS project. Ann Surg 2006;243(1):89-95. doi: 10.1097/01.sla.0000193959.44677.48.Vu L., Nobuhara K., Lee H., Farmer D. Determination of risk factors for deep venous thrombosis in hospitalized children. J Pediatr Surg 2008;43:1095-9. doi: m.1016/j.jpedsurg.2008.02.036.Vu L., Nobuhara K., Lee H., Farmer D. Determination of risk factors for deep venous thrombosis in hospitalized children. J Pediatr Surg 2008;43:1095-9. doi: m.1016/j.jpedsurg.2008.02.036.Manco-Johnson M., Beckman M., Goldenberg N. Risk of postthrombotic syndrome development in children with extremity deep venous thrombosis: results of the US centers of disease control and prevention pediatric thrombosis and hemostasis centers. Blood 2009;114:4000. doi: m.n82/blood.V114.22.4000.4000.Manco-Johnson M., Beckman M., Goldenberg N. Risk of postthrombotic syndrome development in children with extremity deep venous thrombosis: results of the US centers of disease control and prevention pediatric thrombosis and hemostasis centers. Blood 2009;114:4000. doi: m.n82/blood.V114.22.4000.4000.Mitchell L., Andrew M., Hanna K., Abshire T., Halton J., Anderson R., Cherrick I., Desai S., Mahoney D., McCuster P., Wu J., Dahl G., Chait P., de Veber G., Lee K.J., Mikulis D., Ginsberg J., Way C.; Prophylactic Antithrombin Replacement in Kids with Acute Lymphoblastic Leukemia Treated with Asparaginase Group (PARKAA). A prospective cohort study determining the prevalence of thrombotic events in children with acute lymphoblastic leukemia and a central venous line who are treated with l-asparaginase: results of the Prophylactic Antithrombin Replacement in Kids with Acute Lymphoblastic Leukemia Treated with Asparaginase (PARKAA) Study. Cancer 2003;97(2):508-16. doi: m.1002/cncr.n042.Mitchell L., Andrew M., Hanna K., Abshire T., Halton J., Anderson R., Cherrick I., Desai S., Mahoney D., McCuster P., Wu J., Dahl G., Chait P., de Veber G., Lee K.J., Mikulis D., Ginsberg J., Way C.; Prophylactic Antithrombin Replacement in Kids with Acute Lymphoblastic Leukemia Treated with Asparaginase Group (PARKAA). A prospective cohort study determining the prevalence of thrombotic events in children with acute lymphoblastic leukemia and a central venous line who are treated with l-asparaginase: results of the Prophylactic Antithrombin Replacement in Kids with Acute Lymphoblastic Leukemia Treated with Asparaginase (PARKAA) Study. Cancer 2003;97(2):508-16. doi: m.1002/cncr.n042.Haddad T., Greeno E. Chemotherapy-induced thrombosis. Thromb Res 2006;118:555-8. doi: 10.1016/j.thromres.2005.10.015.Haddad T., Greeno E. Chemotherapy-induced thrombosis. Thromb Res 2006;118:555-8. doi: 10.1016/j.thromres.2005.10.015.Nowak-Gottl U., Wermes C., Junker R., Koch H.G., Schobess R., Fleischhack G., Schwabe D., Ehrenforth S. Prospective evaluation of the thrombotic risk in children with acute lymphoblastic leukemia carrying the MTHFR TT 677 genotype, the prothrombin G20210A variant, and further prothrombotic risk factors. Blood 1999;93:1595-9. doi: 10.1182/blood. V93.5.1595.Nowak-Gottl U., Wermes C., Junker R., Koch H.G., Schobess R., Fleischhack G., Schwabe D., Ehrenforth S. Prospective evaluation of the thrombotic risk in children with acute lymphoblastic leukemia carrying the MTHFR TT 677 genotype, the prothrombin G20210A variant, and further prothrombotic risk factors. Blood 1999;93:1595-9. doi: 10.1182/blood. V93.5.1595.Forbrigger Z., Kuhle S., Brown M.M., Moorehead P.C., Digout C., Kulkarni K. The association of venous thromboembolism with survival in pediatric cancer patients: a population-based cohort study. Ann Hematol 2018;97(10):1903-8. doi: 10.1007/s00277-018-3371-0.Forbrigger Z., Kuhle S., Brown M.M., Moorehead P.C., Digout C., Kulkarni K. The association of venous thromboembolism with survival in pediatric cancer patients: a population-based cohort study. Ann Hematol 2018;97(10):1903-8. doi: 10.1007/s00277-018-3371-0.Kuderer N., Culakova E., Lyman G.H., Francis C., Falanga A., Khorana A.A. A validated risk score for venous thromboembolism is predictive of cancer progression and mortality. Oncologist 2016;21(7):861-7. doi: 10.1634/theoncologist.2015-0361.Kuderer N., Culakova E., Lyman G.H., Francis C., Falanga A., Khorana A.A. A validated risk score for venous thromboembolism is predictive of cancer progression and mortality. Oncologist 2016;21(7):861-7. doi: 10.1634/theoncologist.2015-0361.Chew H., Wun T., Harvey D., Zhou H., White R.H. Incidence of venous thromboembolism and its effect on survival among patients with common cancers. Arch Intern Med 2006;166(4):458-64. doi: 10.1001/archinte.166.4.458.Chew H., Wun T., Harvey D., Zhou H., White R.H. Incidence of venous thromboembolism and its effect on survival among patients with common cancers. Arch Intern Med 2006;166(4):458-64. doi: 10.1001/archinte.166.4.458.Khorana A., Kuderer N.M., Culakova E., Lyman G.H., Francis C.W. Development and validation of a predictive model for chemotherapy-associated thrombosis. Blood 2008;111(10):4902-7. doi: 10.1182/blood-2007-10-116327.Khorana A., Kuderer N.M., Culakova E., Lyman G.H., Francis C.W. Development and validation of a predictive model for chemotherapy-associated thrombosis. Blood 2008;111(10):4902-7. doi: 10.1182/blood-2007-10-116327.Ay C., Dunkler D., Marosi C., Chiriac A.L., Vormittag R., Simanek R., Quehenberger P., Zielinski C., Pabinger I. Prediction of venous thromboembolism in cancer patients. Blood 2010;116(24):5377-82. doi: 10.1182/blood-2010-02-270116.Ay C., Dunkler D., Marosi C., Chiriac A.L., Vormittag R., Simanek R., Quehenberger P., Zielinski C., Pabinger I. Prediction of venous thromboembolism in cancer patients. Blood 2010;116(24):5377-82. doi: 10.1182/blood-2010-02-270116.Mitchell L., Lambers M., Flege S., Kenet G., Li-Thiao-Te V., Holzhauer S., Bidlingmaier C., Fruhwald M.C., Heller C., Schmidt W., Pautard B., Nowak-Gottl U. Validation of a predictive model for identifying an increased risk for thromboembolism in children with acute lymphoblastic leukemia: results of a multicenter cohort study. Blood 2010;115(24):4999-5004. doi: 10.U82/blood-2010-01-263012.Mitchell L., Lambers M., Flege S., Kenet G., Li-Thiao-Te V., Holzhauer S., Bidlingmaier C., Fruhwald M.C., Heller C., Schmidt W., Pautard B., Nowak-Gottl U. Validation of a predictive model for identifying an increased risk for thromboembolism in children with acute lymphoblastic leukemia: results of a multicenter cohort study. Blood 2010;115(24):4999-5004. doi: 10.U82/blood-2010-01-263012.Kearon C., Akl E.A., Ornelas J., Blaivas A., Jimenez D., Bounameaux H., Huisman M., King C.S., Morris T.A., Sood N., Stevens S.M., Vintch J.R.E., Wells P., Woller S.C., Moores L. Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report. Chest 2016;149(2):315-52. doi: 10.1016/j.chest.2015.11.026.Kearon C., Akl E.A., Ornelas J., Blaivas A., Jimenez D., Bounameaux H., Huisman M., King C.S., Morris T.A., Sood N., Stevens S.M., Vintch J.R.E., Wells P., Woller S.C., Moores L. Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report. Chest 2016;149(2):315-52. doi: 10.1016/j.chest.2015.11.026.Lyman G., Bohlke K., Khorana A.A., Kuderer N.M., Lee A.Y., Arcelus J.I., Balaban E.P., Clarke J.M., Flowers C.R., Francis C.W., Gates L.E., Kakkar A.K., Key N.S., Levine M.N., Liebman H.A., Tempero M.A., Wong S.L., Somerfield M.R., Falanga A.; American Society of Clinical Oncology. Venous thromboembolism prophylaxis and treatment in patients with cancer: American society of clinical oncology clinical practice guideline update 2014. J Clin Oncol 2015;33(6):654-6. doi: 10.1200/JCO.2014.59.7351.Lyman G., Bohlke K., Khorana A.A., Kuderer N.M., Lee A.Y., Arcelus J.I., Balaban E.P., Clarke J.M., Flowers C.R., Francis C.W., Gates L.E., Kakkar A.K., Key N.S., Levine M.N., Liebman H.A., Tempero M.A., Wong S.L., Somerfield M.R., Falanga A.; American Society of Clinical Oncology. Venous thromboembolism prophylaxis and treatment in patients with cancer: American society of clinical oncology clinical practice guideline update 2014. J Clin Oncol 2015;33(6):654-6. doi: 10.1200/JCO.2014.59.7351.Farge D., Debourdeau P., Beckers M., Baglin C., Bauersachs R.M., Brenner B., Brilhante D., Falanga A., Gerotzafias G.T., Haim N., Kakkar A.K., Khorana A.A., Lecumberri R., Mandala M., Marty M., Monreal M., Mousa S.A., Noble S., Pabinger I., Prandoni P., Prins M.H., Qari M.H., Streiff M.B., Syrigos K., Bounameaux H., Buller H.R. International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer. J Thromb Haemost 2013;11(1):56-70. doi: 10.1111/jth.12070.Farge D., Debourdeau P., Beckers M., Baglin C., Bauersachs R.M., Brenner B., Brilhante D., Falanga A., Gerotzafias G.T., Haim N., Kakkar A.K., Khorana A.A., Lecumberri R., Mandala M., Marty M., Monreal M., Mousa S.A., Noble S., Pabinger I., Prandoni P., Prins M.H., Qari M.H., Streiff M.B., Syrigos K., Bounameaux H., Buller H.R. International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer. J Thromb Haemost 2013;11(1):56-70. doi: 10.1111/jth.12070.Prandoni P., Lensing A.W., Piccioli A., Bernardi E., Simioni P., Girolami B., Marchiori A., Sabbion P., Prins M.H., Noventa F., Girolami A. Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis. Blood 2002;100(10):3484-8. doi: 10.1182/blood-2002-01-0108.Prandoni P., Lensing A.W., Piccioli A., Bernardi E., Simioni P., Girolami B., Marchiori A., Sabbion P., Prins M.H., Noventa F., Girolami A. Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis. Blood 2002;100(10):3484-8. doi: 10.1182/blood-2002-01-0108.Monagle P., Chan A.K.C., Goldenberg N.A., Ichord R.N., Journeycake J.M., Nowak-Gottl U., Vesely S.K. Antithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012;141(2 Suppl):e737S-e801S. doi: 10.1378/chest.11-2308.Monagle P., Chan A.K.C., Goldenberg N.A., Ichord R.N., Journeycake J.M., Nowak-Gottl U., Vesely S.K. Antithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012;141(2 Suppl):e737S-e801S. doi: 10.1378/chest.11-2308.Elhasid R., Lanir N., Sharon R., Ben Arush M.W., Levin C., Postovsky S., Ben Barak A., Brenner B. Prophylactic therapy with enoxaparin during L-asparaginase treatment in children with acute lymphoblastic leukemia. Blood Coagul Fibrinolysis 2001;12(5):367-70. doi: 10.1097/00001721-200107000-00005.Elhasid R., Lanir N., Sharon R., Ben Arush M.W., Levin C., Postovsky S., Ben Barak A., Brenner B. Prophylactic therapy with enoxaparin during L-asparaginase treatment in children with acute lymphoblastic leukemia. Blood Coagul Fibrinolysis 2001;12(5):367-70. doi: 10.1097/00001721-200107000-00005.Harlev D., Zaidman I., Sarig G., Ben Arush M.W., Brenner B., Elhasid R. Prophylactic therapy with enoxaparin in children with acute lymphoblastic leukemia and inherited thrombophilia during L-asparaginase treatment. Thromb Res 2010;126(2):93-7. doi: 10.1016/j.thromres.2010.04.013.Harlev D., Zaidman I., Sarig G., Ben Arush M.W., Brenner B., Elhasid R. Prophylactic therapy with enoxaparin in children with acute lymphoblastic leukemia and inherited thrombophilia during L-asparaginase treatment. Thromb Res 2010;126(2):93-7. doi: 10.1016/j.thromres.2010.04.013.Carman T., Kanner A., Barnett G., Deitcher S. Prevention of thromboembolism after neurosurgery for brain and spinal tumors: a survey. South Med J 2003;96:17-22. doi: 10.1097/01.SMJ.0000047628.44490.B2.Carman T., Kanner A., Barnett G., Deitcher S. Prevention of thromboembolism after neurosurgery for brain and spinal tumors: a survey. South Med J 2003;96:17-22. doi: 10.1097/01.SMJ.0000047628.44490.B2.

The authors declare that there are no conflicts of interest present.